Home > > Global Sacroiliac Joint Fusion Market Report
The Sacroiliac Joint Fusion market was valued at $226.8 Million in 2022, and is projected to reach $426.5 Million by 2032 growing at a CAGR of 6.57% from 2023 to 2032.The sacroiliac joint fusion market is expected to grow in the coming years due to increasing incidence of sacroiliitis, a condition that causes pain in the sacroiliac joint, and the growing adoption of minimally invasive surgical techniques. There are several companies that are actively involved in the development of products and technologies for sacroiliac joint fusion, including: Depuy Synthes: This company, a division of Johnson & Johnson, offers a range of products for sacroiliac joint fusion, including the SImmetry Sacroiliac Joint Fusion System, which is designed to provide stability and support to the sacroiliac joint. Globus Medical: This company offers the Accufuse SIJ Fusion System, which is a minimally invasive device for sacroiliac joint fusion. Stryker: This company offers the MAKOplasty SIJ Fusion System, which uses robotics to assist in the surgical procedure. Zimmer Biomet: This company offers the ROSA SIJ Fusion System, which is a robot-assisted surgical device for sacroiliac joint fusion. In recent years, there has been a trend towards the development of minimally invasive techniques for sacroiliac joint fusion, as these techniques can result in shorter hospital stays and quicker recovery times for patients. There is also an increasing focus on the development of biologic therapies for the treatment of sacroiliitis, as these therapies have the potential to offer a more natural and long-lasting solution to the pain and disability caused by this condition.